InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by GUYER DAVID R, Director. Officer active across 1 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been recorded. The latest transaction was filed on 9 February 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
02,500 shares0
Common Stock
SEC:0001562180-22-001419·
02,500 shares0
Common Stock
SEC:0001562180-22-001419:0·
2 of 2 declarations
About GUYER DAVID R
David R. Guyer is a Director at EyePoint Pharmaceuticals, Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. David brings his expertise and experience to guide EyePoint in its growth and innovation initiatives. His role is essential in ensuring the company's good governance and regulatory compliance.
